Back to today’s briefing

Story perspectives

BioSapien Secures $7M for Cancer-Fighting MediChip Trials

1/29/2025

49 5

Summary

BioSapien Secures Funding

UAE biotech startup BioSapien has secured $7 million in pre-Series A funding, spearheaded by Golden Gate Ventures’ MENA Fund. Since its inception in 2018, BioSapien has innovated the MediChip, a groundbreaking 3D-printed drug delivery system aimed at targeting cancer cells. This funding will accelerate clinical trials in Abu Dhabi, slated for Q2 2025, and broaden treatment options.

Summary

Fincart.io Secures Funding

Egypt's Fincart.io, a promising logistics startup, has successfully wrapped up its pre-seed funding round, spearheaded by Plus VC and supported by key investors. Launched in 2023, Fincart.io is set to revolutionize shipping for small and medium-sized businesses in the booming e-commerce landscape, using the funds to bolster technology and broaden its courier network across Africa and the Middle East.

History

Historical Context

The MENA startup downturn in 2024 echoes the region's historical economic volatility, particularly post-Arab Spring. Economic reforms, driven by neoliberal policies since the 1980s, often led to wealth concentration and social unrest. Current fintech growth amidst this decline reflects ongoing challenges in achieving sustainable economic equity.

1 of 3

BioSapien Secures Funding

UAE biotech startup BioSapien has secured $7 million in pre-Series A funding, spearheaded by Golden Gate Ventures’ MENA Fund. Since its inception in 2018, BioSapien has innovated the MediChip, a groundbreaking 3D-printed drug delivery system aimed at targeting cancer cells. This funding will accelerate clinical trials in Abu Dhabi, slated for Q2 2025, and broaden treatment options.

1 / 3